Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Queensland Health
McKesson
Citi
Federal Trade Commission
Chubb
McKinsey
Medtronic
Argus Health
Cipla

Generated: August 22, 2017

DrugPatentWatch Database Preview

ERYTHROMYCIN ETHYLSUCCINATE Drug Profile

« Back to Dashboard

Which patents cover Erythromycin Ethylsuccinate, and what generic Erythromycin Ethylsuccinate alternatives are available?

Erythromycin Ethylsuccinate is a drug marketed by Alpharma Us Pharms, Arbor Pharms Llc, Parke Davis, Mylan, Ani Pharms Inc, Barr, Pharmafair, Naska, and Dista. and is included in eleven NDAs.

The generic ingredient in ERYTHROMYCIN ETHYLSUCCINATE is erythromycin ethylsuccinate; sulfisoxazole acetyl. There are ninety-eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate; sulfisoxazole acetyl profile page.

Summary for Tradename: ERYTHROMYCIN ETHYLSUCCINATE

Patents:0
Applicants:9
NDAs:11
Suppliers / Packagers: see list3
Bulk Api Vendors: see list23
Clinical Trials: see list92
Patent Applications: see list548
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ERYTHROMYCIN ETHYLSUCCINATE at DailyMed

Pharmacology for Tradename: ERYTHROMYCIN ETHYLSUCCINATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms
ERYTHROMYCIN ETHYLSUCCINATE
erythromycin ethylsuccinate
SUSPENSION;ORAL062200-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ani Pharms Inc
ERYTHROMYCIN ETHYLSUCCINATE
erythromycin ethylsuccinate
GRANULE;ORAL062055-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Parke Davis
ERYTHROMYCIN ETHYLSUCCINATE
erythromycin ethylsuccinate
SUSPENSION;ORAL062231-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Dista
ERYTHROMYCIN ETHYLSUCCINATE
erythromycin ethylsuccinate
SUSPENSION;ORAL062177-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Barr
ERYTHROMYCIN ETHYLSUCCINATE
erythromycin ethylsuccinate
TABLET;ORAL062256-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
UBS
Healthtrust
Daiichi Sankyo
Harvard Business School
AstraZeneca
Express Scripts
Federal Trade Commission
Cantor Fitzgerald
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot